While total plasma levels of α-synuclein show no change, neuronal exosomal α-synuclein correlate with disease progression in PD, indicating that an assessment of neuronal exosomes from plasma may be a superior strategy for biomarker discovery in other neurodegenerative diseases [115]. The gene discussed is SNCA; the disease is neurodegenerative disease.